FDA inspection
Lupin Laboratories, Ltd.: FDA inspection ending Aug 19, 2022
FDA inspection 1177847 · Voluntary Action Indicated (VAI) · Ankleshwar
Key facts
| Inspection ID | 1177847 |
|---|---|
| Firm | Lupin Laboratories, Ltd. |
| FEI number | 3002807510 |
| Address | 124 Gidc Industrial Estate |
| City | Ankleshwar |
| Fiscal year | 2022 |
| Inspection end date | Aug 19, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data